Sameer Agarwal is a pharma leader with 30 years global experience, thereof more than 15 years senior executive level experience for Fresenius Kabi & Dabur Pharma with responsibilities for strategy, portfolio management, acquisitions, licensing, general management, sales & marketing. He has headed global pharma businesses in USA, China & rest of Asia, Europe, Russia and South America, covering key product types including oncology, biosimilars, pain management, anaesthesia, anti-infective and critical care. Sameer is also experienced in business development, IP, regulatory, pharmaceutical analysis and bioequivalence studies. He presently resides in Germany and has previously lived and worked from USA, Hong Kong, and India
Molecular Cell Biology and Genetics